1. Home
  2. MCRB vs NIPG Comparison

MCRB vs NIPG Comparison

Compare MCRB & NIPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCRB
  • NIPG
  • Stock Information
  • Founded
  • MCRB 2010
  • NIPG 2014
  • Country
  • MCRB United States
  • NIPG Sweden
  • Employees
  • MCRB N/A
  • NIPG N/A
  • Industry
  • MCRB Biotechnology: Pharmaceutical Preparations
  • NIPG
  • Sector
  • MCRB Health Care
  • NIPG
  • Exchange
  • MCRB Nasdaq
  • NIPG NYSE
  • Market Cap
  • MCRB 103.7M
  • NIPG 96.4M
  • IPO Year
  • MCRB 2015
  • NIPG 2024
  • Fundamental
  • Price
  • MCRB $12.09
  • NIPG $2.41
  • Analyst Decision
  • MCRB Hold
  • NIPG Strong Buy
  • Analyst Count
  • MCRB 4
  • NIPG 1
  • Target Price
  • MCRB $73.67
  • NIPG $6.00
  • AVG Volume (30 Days)
  • MCRB 109.0K
  • NIPG 406.8K
  • Earning Date
  • MCRB 08-12-2025
  • NIPG 04-30-2025
  • Dividend Yield
  • MCRB N/A
  • NIPG N/A
  • EPS Growth
  • MCRB N/A
  • NIPG N/A
  • EPS
  • MCRB 8.98
  • NIPG N/A
  • Revenue
  • MCRB N/A
  • NIPG $85,266,306.00
  • Revenue This Year
  • MCRB N/A
  • NIPG $11.25
  • Revenue Next Year
  • MCRB N/A
  • NIPG $33.33
  • P/E Ratio
  • MCRB $1.50
  • NIPG N/A
  • Revenue Growth
  • MCRB N/A
  • NIPG 1.91
  • 52 Week Low
  • MCRB $6.53
  • NIPG $0.99
  • 52 Week High
  • MCRB $30.60
  • NIPG $17.76
  • Technical
  • Relative Strength Index (RSI)
  • MCRB 66.74
  • NIPG N/A
  • Support Level
  • MCRB $10.67
  • NIPG N/A
  • Resistance Level
  • MCRB $12.84
  • NIPG N/A
  • Average True Range (ATR)
  • MCRB 1.09
  • NIPG 0.00
  • MACD
  • MCRB 0.34
  • NIPG 0.00
  • Stochastic Oscillator
  • MCRB 85.98
  • NIPG 0.00

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About NIPG NIP GROUP INC SPON ADS EACH REPR 2 CL A ORD SHS

NIP Group Inc is a digital entertainment company built for the growing gaming and esports industry. NIP Group integrates multiple businesses such as talent agency, event production, game-themed hotels and game publishing to create transformative entertainment experiences that inspire, connect fans, expand influence globally, and achieve deep interaction on platforms where digital native players gather. It currently has operation centers in Sweden, China, Abu Dhabi, and Brazil, and its esports teams cover multiple game projects and are active in the top event stages.

Share on Social Networks: